Results 191 to 200 of about 340,285 (357)
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler +4 more
wiley +1 more source
Interferon regulatory factors: the next prospective targets for tissue ischemia-reperfusion injury? [PDF]
Xie J +7 more
europepmc +1 more source
Announcement: Spotlight on Reducing the Impact of Myocardial Ischaemia/Reperfusion Injury [PDF]
openalex +1 more source
Abstract Sodium‐glucose co‐transporters (SGLTs) mediate sodium and glucose transport across cell membranes. SGLT2 inhibitors have a recognized place within heart failure (HF) guidelines. We evaluated the effect of sotagliflozin on HF and cardiovascular outcomes in participants with type 2 diabetes. Scopus, Medline, Embase and Central were searched from
Maria Anna Bantounou +7 more
wiley +1 more source
Mitochondria in Renal Ischemia-Reperfusion Injury: From Mechanisms to Therapeutics. [PDF]
Pan Y, Zhu J.
europepmc +1 more source
A contemporary simple risk score for prediction of severe AKI after HT. Abstract Background The aim of this study was to develop a simple risk score to estimate severe acute kidney injury (AKI) risk based on a large contemporary heart transplantation (HT) cohort.
Shuangshuang Zhu +10 more
wiley +1 more source
Spirulina Preconditioning Attenuates Ischemia-Reperfusion Injury in a Steatotic Rat Liver Model. [PDF]
Baily E +7 more
europepmc +1 more source

